The Scientific Value of Stool Samples: Insights from the Global Microbiome Conservancy

The Global Microbiome Conservancy (GMbC), co-founded by Mathilde Poyet and Mathieu Groussin, operates a laboratory in Kiel, Germany, dedicated to studying the human gut microbiome through stool samples. Over the past nine years, the GMbC has collected samples from 50 populations across 19 countries, including Ghana, Tanzania, Finland, and Thailand. These samples are stored in a –80 ºC freezer, equipped with a backup battery system to ensure their preservation.

Nature

Stool samples provide a critical window into human health, serving as a snapshot of the gut microbiome, which varies across different populations. Groussin emphasizes that stool analysis is the best method to access the biodiversity of gut organisms. The GMbC's research aligns with broader scientific efforts, as stool samples are increasingly recognized for their potential in public health monitoring, particularly in wastewater analysis to track pathogens, as demonstrated by Janelle Thompson's work in Singapore.

Nature

Stool samples are not only valuable for public health but also for medical treatments. Research into fecal microbiota transplants has shown promise in treating Clostridium difficile infections, which arise from an imbalanced microbiota. Josbert Keller, a gastroenterologist, notes that these transplants can restore a healthy microbiome, preventing recurrent infections. The potential applications of fecal transplants are expanding, with ongoing studies exploring their effects on obesity, type 2 diabetes, and Parkinson's disease.

Nature

The study of human waste extends beyond health applications. Researchers are investigating the use of urine as a nitrogen-rich fertilizer amid global fertilizer shortages. A Stanford University study highlights the feasibility of extracting nutrients from urine, which could generate significant economic benefits while also reducing greenhouse gas emissions and conserving water.

Nature

Despite the scientific advancements, there remains a cultural stigma surrounding the study of feces. Marine Legrand, an anthropologist, points out that funding for research on feces is often less accessible than for urine, reflecting societal discomfort with the subject. This cultural barrier can hinder the exploration of the full potential of waste materials in both medical and agricultural contexts.

Nature

• “It’s our best way to interrogate what’s in the gut from healthy people,” — Mathieu Groussin, Co-founder, Global Microbiome Conservancy

Nature

• “The waste we put into the environment is really data rich,” — Janelle Thompson, Environmental Microbiologist, Nanyang Technological University

Nature

• “If the patient is not able to restore this microbiota, then it can recur and recur, and that’s the moment that faecal microbiota transplants can really cure a patient.” — Josbert Keller, Gastroenterologist, Haaglanden Medical Centre

Nature

• “We just have to kind of get past that hurdle to discover all the information that it contains.” — Bryn Nelson, Author and Former Microbiologist

Nature

The research conducted by the Global Microbiome Conservancy underscores the significant scientific value of stool samples in understanding human health and disease. While the potential applications are vast, addressing cultural taboos and securing funding for fecal research remain challenges that the scientific community must navigate to fully harness this resource.

Nature